Podcast Episode Details
Back to Podcast Episodes
E94 Rohit Nambisan, President at Lokavant
In this episode, host JP Valentine sits down with Rohit Nambisan, President at Lokavant in New York. Lokavant is a technology company whose mission is to ensure that no clinical trial fails due to operational error. By integrating and analyzing the disparate data sources within clinical trials, Lokavant provides real-time visualizations and risk alerts to study sponsors and CROs to enable data-driven decisions. These insights expedite trial timelines and reduce the costs of development, allowing safe and efficacious treatments to get to patients.
Lokavant centralizes trial data to power a machine learning model that anticipates trial risk, provides data-driven risk mitigation strategies and predicts the impact of mitigation strategy implementation. Lokavant's anticipatory monitoring capability is grounded in a compendium of data from over 1,000 clinical trials and will improve with each deployment.
In the show, Rohit will share with you:
How Lokavant aim to impact the Healthcare sector,
Using data to positively impact clinical trials,
How the Coronavirus pandemic is disrupting clinical trials,
Lokovant’s solutions in response to COVID-19,
Why he loves working in the Healthtech industry,
and What the future looks like for Lokavant
Published on 5 years, 6 months ago